QI
BIIB icon

Qtron Investments’s Biogen BIIB Stock Holding History

Qtron Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-837
Closed -$217K – 478
2023
Q4 		$217K Sell
837
-294
-26% -$72.2K 0.04% 448
2023
Q3 		$291K Sell
1,131
-1,271
-53% -$340K 0.06% 363
2023
Q2 		$684K Sell
2,402
-504
-17% -$150K 0.13% 211
2023
Q1 		$808K Hold
2,906
– – 0.17% 166
2022
Q4 		$805K Buy
2,906
+853
+42% +$241K 0.17% 162
2022
Q3 		$548K Buy
+2,053
New +$436K 0.14% 210
2021
Q1 		– Sell
-854
Closed -$209K – 334
2020
Q4 		$209K Sell
854
-247
-22% -$63.7K 0.06% 315
2020
Q3 		$312K Sell
1,101
-372
-25% -$104K 0.11% 217
2020
Q2 		$394K Hold
1,473
– – 0.16% 167
2020
Q1 		$466K Buy
+1,473
New +$447K 0.28% 122

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qtron Investments's BIIB Position: Q1 2024 in Review

Qtron Investments sold out of Biogen (BIIB) in Q1 2024, closing a stake of 837 shares — an estimated $217K sold.

Qtron Investments first reported a position in BIIB in Q1 2020 and held it in 10 quarters. The position peaked at $808K in Q1 2023. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Qtron Investments reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Qtron Investments sold 837 Biogen shares in Q1 2024, an estimated $217K.
  • Qtron Investments first reported a position in Biogen in Q1 2020 and held it in 10 quarters.
  • Qtron Investments's Biogen position peaked at $808K in Q1 2023.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Qtron Investments's 13F filing for Q1 2024, filed 14 May 2024.